NCT02553395

Brief Summary

This study will investigate performance criteria over one week of daily wear to determine if the Study Test contact lens performs equivalently to the comfilcon A contact lenses in terms of subjective ratings and of visual performance. The study test lens was not the final optical design and the study results were not used for the design validation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

September 14, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 17, 2015

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
5.2 years until next milestone

Results Posted

Study results publicly available

December 22, 2020

Completed
Last Updated

December 22, 2020

Status Verified

November 1, 2020

Enrollment Period

Same day

First QC Date

September 14, 2015

Results QC Date

September 29, 2020

Last Update Submit

November 30, 2020

Conditions

Outcome Measures

Primary Outcomes (11)

  • Binocular Distance Visual Acuity (VA) - High Illumination High Contrast

    Binocular Distance visual acuity High Illumination High Contrast was assessed using logMAR (0.02 logMAR= 1 letter)

    Baseline - After 5 minutes of lens settling

  • Binocular Distance Visual Acuity (VA) -High Illumination High Contrast

    Binocular Distance visual acuity High Illumination High Contrast was assessed using logMAR (0.02 logMAR= 1 letter)

    1 week

  • Binocular Near Visual Acuity (VA) - High Illumination High Contrast

    Binocular Near Visual Acuity High Illumination High Contrast was assessed on logMAR VA (0.02 logMAR= 1 letter)

    Baseline - after 5 minutes of lens dispense

  • Binocular Near Visual Acuity (VA) - High Illumination High Contrast

    Binocular Near Visual Acuity High Illumination High Contrast was assessed on logMAR VA (0.02 logMAR= 1 letter)

    1-week

  • Binocular Distance Visual Acuity (VA) - Low Illumination High Contrast

    Binocular Distance Visual Acuity (VA) - Low Illumination High Contrast was assessed using logMAR VA (0.02 logMAR= 1 letter)

    Baseline (After 5 minutes of lens settling)

  • Binocular Distance Visual Acuity (VA) - Low Illumination High Contrast

    Binocular Distance Visual Acuity (VA) - Low Illumination High Contrast was assessed using logMAR VA (0.02 logMAR= 1 letter)

    1 week

  • Binocular Near Visual Acuity (VA) - Low Illumination High Contrast

    Binocular Near Visual Acuity (VA) - Low Illumination High Contrast was assessed using logMAR VA (0.02 logMAR= 1 letter)

    Baseline (after 5 minutes of lens settling)

  • Binocular Near Visual Acuity (VA) - Low Illumination High Contrast

    Binocular Near Visual Acuity (VA) - Low Illumination High Contrast was assessed using logMAR VA (0.02 logMAR= 1 letter)

    1week

  • Subjective Ratings for Distance Quality of Vision

    Patient subjective scoring using anchors on the scale to provide a score between 0-100 for Distance Quality of Vision: (0=extremely poor vision all of the time. Cannot function; 20= Frequently annoying vision problems; 40=Occasionally annoying vision problems; 60=occasionally noticeable but not annoying vision problems; 80=rarely noticeable vision problems; 100=excellent vision all of the time)

    1 week

  • Subjective Ratings for Intermediate Quality of Vision

    Patient subjective scoring using anchors on the scale to provide a score between 0-100 for Intermediate Quality of Vision: (0=extremely poor vision all of the time. Cannot function; 20= Frequently annoying vision problems; 40=Occasionally annoying vision problems; 60=occasionally noticeable but not annoying vision problems; 80=rarely noticeable vision problems; 100=excellent vision all of the time)

    1 week

  • Subjective Ratings for Near Quality of Vision

    Patient subjective scoring using anchors on the scale to provide a score between 0-100 for Near Quality of Vision: (0=extremely poor vision all of the time. Cannot function; 20= Frequently annoying vision problems; 40=Occasionally annoying vision problems; 60=occasionally noticeable but not annoying vision problems; 80=rarely noticeable vision problems; 100=excellent vision all of the time)

    1 week

Secondary Outcomes (12)

  • Post Blink Movement -

    Baseline (After 5 minutes of lens dispense)

  • Post Blink Movement

    1 week

  • Push - Up Test for Lens Tightness

    Baseline (After 5 minutes of lens dispense)

  • Push - Up Test for Lens Tightness

    1 week

  • Lens Mobility Rating

    Baseline (after 5 minutes of lens dispense)

  • +7 more secondary outcomes

Study Arms (2)

Phenacite contact lens

EXPERIMENTAL

Study Test Contact Lens

Device: Phenacite (Test) contact lens

comfilcon A contact lens

ACTIVE COMPARATOR

Control Contact Lens

Device: comfilcon A contact lens

Interventions

Phenacite contact lens
comfilcon A contact lens

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Oculo-visual examination in the last two years
  • Between 18 and 35 years of age and has full legal capacity to volunteer
  • Has read and understood the informed consent letter
  • Is willing and able to follow instructions and maintain the appointment schedule
  • Is correctable to a visual acuity of 20/25 or better (in each eye) with their habitual correction or 20/20 best corrected
  • Currently wears, or has previously successfully worn, soft contact lenses between -1.00D (Diopter) and -4.50D
  • Spherical Contact Lens Rx between -1.00 and -4.00 and spectacle cylinder \<-0.75
  • Currently spends a minimum of 4 hours a day; 5 days a week on digital devices and can replicate this time during the study period
  • Is willing and able to wear the study contact lenses a minimum of 10 hours per day; 5 days a week.

You may not qualify if:

  • A person will be excluded from the study if he/she:
  • Has never worn contact lenses before.
  • Has any systemic disease affecting ocular health.
  • Is using any systemic or topical medications that will affect ocular health.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.
  • Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
  • Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
  • Is aphakic.
  • Has undergone corneal refractive surgery.
  • Is participating in any other type of eye related clinical or research study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University

Bloomington, Indiana, 47405, United States

Location

MeSH Terms

Conditions

Myopia

Interventions

Contact Lenses

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Intervention Hierarchy (Ancestors)

LensesOptical DevicesEquipment and Supplies

Results Point of Contact

Title
Paul Chamberlain
Organization
CooperVision Inc.

Study Officials

  • Peter Kollbaum, OD, PhD

    Clinical Optics Research Lab (CORL)

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 14, 2015

First Posted

September 17, 2015

Study Start

September 1, 2015

Primary Completion

September 1, 2015

Study Completion

October 1, 2015

Last Updated

December 22, 2020

Results First Posted

December 22, 2020

Record last verified: 2020-11

Locations